Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 1985 - 2000 of 91813 for .

Showing results 1985 - 2000 of 91813 for .

The Tale of a Real-life SEND Test Submission
What to Expect When Submitting Your First SEND Dataset to the FDA. With the December 17, 2016* requirement for the FDA Standard for the Exchange of Nonclinical Data (SEND*) fast-approaching, our Covance SEND action team prepared a dataset for test submission to the FDA. This helped us to better understand the FDA's SEND submission requirements, build experience and confirm our readiness to help clients submit their SEND datasets.
TQT Waivers: One Year Later
ICH E14 REGULATORY GUIDANCE 2005 AND 2015 It has been one year since the International Conference on Harmonisation (ICH) updated its 2005 cardiac safety guidelines. The 2015 update allows for specific QT interval analysis based upon concentration effect modeling up to supratherapeutic during Phase I as a reasonable substitute for a Thorough-QT (TQT) dedicated trial.
Global Cardiovascular/Metabolic Experience in Central Laboratory Services
Number of cardiovascular/metabolic studies performed in Central Laboratory Services.
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video
Limelight Video